📰 Ananda Scientific News
Ananda Scientific News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Ananda Scientific. Real-time updates on events, politics, business and more.
March 28, 2023
ANANDA Scientific Inc., a research focused bio-pharmaceutical company today announced that the first subject has been enrolled in the clinical trial with an FDA-approved IND evaluating Nantheia™ A1002N5S, an investigational drug using cannabidiol (CBD) in ANANDA’s proprietary Liquid Structure™ delivery technology as a potential treatment for Social Anxiety Disorder (SAD).
July 26, 2022
GREENWOOD VILLAGE, Colo. and LOS ANGELES, July 26, 2022 /PRNewswire/ -- ANANDA Scientific Inc., a research focused bio-pharmaceutical company today announced the first patient enrolled in the
May 18, 2022
Ananda Scientific announced a collaboration with University of Nebraska Medical Center on a post-traumatic stress disorder (PTSD) treatment.
January 9, 2022
Ananda Scientific says it has been approved by the FDA to kick off a clinical trial evaluating CBD in treating Opioid Use Disorder.
November 5, 2021
/PRNewswire/ -- According to the Coherent Market Insights, The global cannabidiol market is estimated to account for 55,200.2 Mn in terms of value by the end...
November 5, 2021
/PRNewswire/ -- According to the Coherent Market Insights, The global cannabidiol market is estimated to account for 55,200.2 Mn in terms of value by the end...
November 5, 2021
SEATTLE, Nov. 5, 2021 /PRNewswire/ -- According to the Coherent Market Insights, The global cannabidiol market is estimated to account for 55,200.2 Mn in terms of value by the end of 2028. Cannabidiol